Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus
about
Current treatment practice in immunosuppression.Gene expression profiling to study racial differences after heart transplantationDonor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity.Bone marrow augmentation in renal transplant recipients.
P2860
Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Striking augmentation of hemat ...... by FLT3 ligand and tacrolimus
@ast
Striking augmentation of hemat ...... by FLT3 ligand and tacrolimus
@en
Striking augmentation of hemat ...... by FLT3 ligand and tacrolimus
@nl
type
label
Striking augmentation of hemat ...... by FLT3 ligand and tacrolimus
@ast
Striking augmentation of hemat ...... by FLT3 ligand and tacrolimus
@en
Striking augmentation of hemat ...... by FLT3 ligand and tacrolimus
@nl
prefLabel
Striking augmentation of hemat ...... by FLT3 ligand and tacrolimus
@ast
Striking augmentation of hemat ...... by FLT3 ligand and tacrolimus
@en
Striking augmentation of hemat ...... by FLT3 ligand and tacrolimus
@nl
P2093
P2860
P1433
P1476
Striking augmentation of hemat ...... by FLT3 ligand and tacrolimus
@en
P2093
A R Iyengar
A W Thomson
C A Bonham
M A Antonysamy
V M Subbotin
P2860
P304
P356
10.1097/00007890-199705150-00001
P577
1997-05-01T00:00:00Z